|
USP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.64879999995116E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.44990000000767E-06 |
| Normal-vs-Stage2 |
1.541170E-03 |
| Normal-vs-Stage3 |
6.458100E-03 |
| Normal-vs-Stage4 |
1.215750E-01 |
| Stage1-vs-Stage2 |
7.247800E-01 |
| Stage1-vs-Stage3 |
6.718600E-01 |
| Stage1-vs-Stage4 |
7.357800E-01 |
| Stage2-vs-Stage3 |
4.927600E-01 |
| Stage2-vs-Stage4 |
5.649400E-01 |
| Stage3-vs-Stage4 |
9.469200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53774999999134E-05 |
| Normal-vs-AfricanAmerican |
5.961400E-04 |
| Normal-vs-Asian |
3.283200E-03 |
| Caucasian-vs-AfricanAmerican |
7.669400E-01 |
| Caucasian-vs-Asian |
6.043000E-01 |
| AfricanAmerican-vs-Asian |
4.782400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.70120000034346E-07 |
| Normal-vs-Female |
8.834300E-02 |
| Male-vs-Female |
4.435100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.004600E-04 |
| Normal-vs-Extreme_Weight |
1.63518999999335E-05 |
| Normal-vs-Obese |
5.596100E-03 |
| Normal-vs-Extreme_Obese |
2.029600E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.966800E-01 |
| Normal_Weight-vs-Obese |
2.668800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.417800E-01 |
| Extreme_Weight-vs-Obese |
1.559380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.927600E-01 |
| Obese-vs-Extreme_Obese |
1.911590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.104600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.018700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.36750000048858E-07 |
| Normal-vs-Age(81-100Yrs) |
4.401200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.912400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.285700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.299500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.612200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.640500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.265600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.46350000000706E-05 |
| Normal-VS-Type2 PRCC |
2.11839999986196E-08 |
| Normal-VS-KIRP CIMP |
5.461200E-01 |
| Normal-VS-Unclassified PRCC |
9.697500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.768000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.913530E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.531400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.640600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.700300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.329500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.90880019860174E-10 |
| Normal-vs-N1 |
8.067800E-01 |
| Normal-vs-N2 |
1.478970E-01 |
| N0-vs-N1 |
4.816800E-03 |
| N0-vs-N2 |
1.582990E-01 |
| N1-vs-N2 |
5.689400E-01 |
|
|
